Orthopedic Surgeon in Cannes to Talk About His Own Experiences Regarding Stem Cell Treatments Used in Cosmetic Surgery.

Online, May 19, 2013 (Newswire.com) - Dr. Mehling, who is founder of Blue Horizon International, will openly discuss the effects of receiving stem cell treatments. The medical professional has completed 11 stem cell treatments and one stem cell facelift. Potentially no other person has concluded as many treatments; especially one who works within the stem cell field. The Blue Horizon International team will also be on hand to answer questions, and will be joined by patient Klara Doert who has recently enjoyed the benefits of a stem cell facelift.

"The interest from the people attending the annual film festival has been overwhelming," stated the doctor. "Everyone wants to learn more about the use of stem cells in cosmetic surgery."

During the visit, a special private event will take place at Villa Horizon Blue in Cannes for invited guests and members of the press. The work of Blue Horizon International will be discussed at the gathering. A clip from a documentary Dr. Mehling is currently producing on stem cell treatments will also be featured.

Dr. Brian Mehling, in addition to being an orthopedic surgeon and founder of Blue Horizon International and Blue Horizon Stem Cell, is a film producer whose production company Industrial Motion Pictures recently produced the film Tiny Tears. The project focuses on children who have been affected by the HIV virus in Thailand, Uganda, Brazil and America.

Blue Horizon International is a healthcare consulting company with a unique concept that combines treatment, research and philanthropic efforts. Blue Horizon International provides quality care and service for medical treatments globally, advanced technologies in stem cell therapies, and also provides resources needed to assist children and adults who are medically underserved. For more information please visit Blue Horizon International at www.bluehorizoninternational.com

Blue Horizon Stem Cells is a division of Blue Horizon International that provides stem cell therapy and research to achieve health benefits. Uniquely positioned to take advantage of its clinical research, Blue Horizon Stem Cell has safely and efficiently performed over 2250 procedures, documenting each procedure while tracking the progress of patients throughout their treatment cycle. Blue Horizon International's stem cell therapy program is associated with The Stem Cell Centre, Hongqiao Brain Hospital and Wuhan University School of Basic Medical Science, Wuhan, China. For more information visit www.bluehorizonstemcells.com